Piper Sandler Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $18
BTIG Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $20
Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $19
Correction to Warby Parker Rating Headlines
Warby Parker Raised to Buy From Neutral by Deutsche Bank
Warby Parker Analyst Ratings
Goldman Sachs Upgrades Warby Parker(WRBY.US) to Buy Rating, Raises Target Price to $18
Loop Capital Maintains Warby Parker(WRBY.US) With Hold Rating, Maintains Target Price $16
CFRA Initiates Warby Parker(WRBY.US) With Buy Rating, Announces Target Price $20
Warby Parker Price Target Announced at $20.00/Share by JMP Securities
Warby Parker Analyst Ratings
JMP Securities Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $20
JMP Securities Upgrades Warby Parker(WRBY.US) to Buy Rating, Announces Target Price $20
Piper Sandler Maintains Warby Parker(WRBY.US) With Buy Rating, Cuts Target Price to $18
Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Doximity (DOCS) and Warby Parker (WRBY)
Loop Capital Markets Reaffirms Their Hold Rating on Warby Parker (WRBY)
JMP Securities Reaffirms Their Hold Rating on Warby Parker (WRBY)
Buy Rating Affirmed: Warby Parker's Robust Q2 Performance and Positive Financial Outlook
Warby Parker Analyst Ratings
Telsey Advisory Sticks to Its Buy Rating for Warby Parker (WRBY)
No Data
No Data